Page 187 - Read Online
P. 187

Page 4 of 7                               Meng et al. J Cancer Metastasis Treat 2019;5:21  I  http://dx.doi.org/10.20517/2394-4722.2018.96

               Table 1. List of mRNAs encoding for mRNA splicing factors identified by MTDH PAR-CLIP or HITS-CLIP
                Ref Seq#             Gene        #PAR-CLIP       Ref Seq#          Gene         #PAR-CLIP
                NM_006924            SRSF1           16          NM_004698         PRPF3           6
                NM_003016            SRSF2           14          NM_014502         PRPF19          11
                NM_003017            SRSF3*          7           NM_015629         PRPF31          3
                NM_005626            SRSF4           8           NM_006109         PRMT5           7
                NM_001039465         SRSF5           9           NM_014706         SART3           8
                NM_006275            SRSF6           13          NM_018047         RBM22           5
                NM_001031684         SRSF7           5           NM_012321         LSM4            5
                NM_003769            SRSF9           7           NM_000344         SMN1            1
                NM_054016            SRSF10          5           NM_015721         GEMIN4          11
                NM_001190987         SRSF11          10          NM_015465         GEMIN5          4
                NM_003090            SNRPA1          5           NM_024707         GEMIN7          3
                NM_198216            SNRPB*          4           NM_024707         HNRNPA1*        7
                NM_003093            SNRPC           5           NM_031157         HNRNPA2B1*      12
                NM_006938            SNRPD1          3           NM_031243         HNRNPA3*        29
                NM_004597            SNRPD2*         5           NM_194247         HNRNPH3*        10
                NM_004175            SNRPD3          11          NM_012207         HNRNPK*         10
                NM_003094            SNRPE           3           NM_002140         HNRNPL*         6
                NM_003095            SNRPF           2           NM_001005335      HNRPU*          17
                NM_003096            SNRPG           3           NM_004501         HNRNPUL2*       14
                NM_022805            SNRPN           4           NM_001079559      PCBP1*          10

               *MTDH interacting mRNAs identified in both High-throughput sequencing of RNA isolated by Cross-linking immunoprecipitation (HITS-
               CLIP) and Photoactivatable Ribonucleoside-Enhanced Cross-linking and Immunoprecipitation (PAR-CLIP)




               TDP43, CPEB2A/B AND ESRP1/RBFOX2 IN BREAST CANCER METASTASIS
                      [22]
               Ke et al.  reported that the loss of TDP43 (TAR DNA-binding protein 43), an important splicing regulator
               involved in the SRSF3 regulated unique splicing of downstream gene PAR3, promotes metastasis in TNBC.
               Highly expressed TDP43 is correlated with poor prognosis in TNBC. Knockdown of TDP43 inhibits
               SRSF3 and PAR3 mediated metastasis. Two CPEB2 splicing isoforms with or without exon 4 was reported
               to mediate opposing effects on cancer-related phenotypes. The CPEB2A isoform, which is produced by
               exclusion of exon 4 from the mature CPEB2 mRNA, inhibited tumor growth. The CPEB2B splicing isoform
               with the inclusion of exon 4 into the mature CPEB2 mRNA was overexpressed in aggressive forms of human
                                                                  [23]
               breast cancer and enhanced cancer metastasis was observed . CPEB2A/B promotes the translation of two
                                                                                     [23]
               critical downstream proteins TWIST1 and HIF1a in the hypoxia/EMT pathway . Splicing factor ratio
               might be an index of EMT and tumor aggressiveness in breast cancer. In fact, the association of low ESRP1/
               RBFOX2 ratio with high risk of metastasis in early breast cancer was speculated to be a new early prognostic
                                            [24]
               marker of breast cancer metastasis .

               RNA BINDING PROTEIN RBM47 INHIBITS BREAST CANCER METASTASIS BY REGULATING

               SPLICING
               RNA binding motif protein 47 (RBM47) was identified as a suppressor of breast cancer metastasis
               through analysis of clinical breast cancer gene expression datasets, cell line models, and mutation data.
               Transcriptome-wide HITS-CLIP analysis revealed widespread mRNAs associated with RBM47 by binding to
               their introns and 3’UTRs. The dickkopf WNT signaling pathway inhibitor 1 (DKK1) is one of downstream
               mRNAs of RBM47. RBM47 inhibits breast cancer metastasis by increasing stability of the Wnt antagonist
                    [25]
               DKK1 .

               NON-CODING RNA REST-003 PROMOTES BREAST CANCER METASTASIS
   182   183   184   185   186   187   188   189   190   191   192